Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
5
×
life sciences
5
×
national blog main
biotech
amgen
boston blog main
boston top stories
detroit blog main
detroit top stories
eli lilly
national
national top stories
new york blog main
san diego blog main
san diego top stories
abbvie
acute hepatic porphyrias
akin akinc
alder biopharmaceuticals
allergan
alnylam pharmaceuticals
aminolevulinic acid
bempedoic acid
bial
biohaven
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cgpr
cholesterol
chronic migraine
corticosteroids
david rind
detroit
drug development
drugs
episodic migraine
eptinezumab
What
fda
5
×
nod
5
×
drug
medicines
pill
approval
approved
class
gets
migraine
new
second
wins
add
adults
ago
allergan
alnylam
amgen
called
candidates
carbidopa
cholesterol
combination
combo
control
daily
developed
disease
esperion
esperion’s
experience
head
indicated
interference
levels
levodopa
lowering
medication
medicine
Language
unset
Current search:
fda
×
fda
×
" life sciences "
×
nod
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines